Stock listing
OTC:PXMD PaxMedica, Inc. Stock
Home listing (OTC) of PaxMedica, Inc.
Follow PaxMedica, Inc. into a list and get an email when it puts out news.
Share price · OTC:PXMD
$0.0005 USD 0.0000 (0.0%)
Close on Nov 18, 2026
- Day range
- $0.0005 – $0.0005 USDNov 18, 2026
- Volume
- 20,701 sharesNov 18, 2026
- Market cap
- $63,132 USDAt the close on Nov 18, 2026 · price × 126.3M shares outstanding
- 52-week range
- $0.0001 – $0.0200 USDLowest and highest trades, Nov 19, 2025 – Nov 18, 2026
- Traded on an average day
- $1 USDMedian day 0 shares · 42 days with no trades · last 3 months, Aug 18, 2026 – Nov 18, 2026

Prices by listing
| Listing | Last | Change | Volume | Open | High | Low | Previous close | Price from |
|---|---|---|---|---|---|---|---|---|
| OTC:PXMD · Home | $0.0005 USD | 0.0000 (0.0%) | 20,701 | $0.0005 | $0.0005 | $0.0005 | $0.0005 | Close on Nov 18, 2026 |
Daily closes
Last 3 months, Aug 18, 2026 – Nov 18, 2026 · OTC:PXMD · USD, adjusted for splits
| Day | Close | Change | % | Open | High | Low | Volume |
|---|---|---|---|---|---|---|---|
| $0.0005 | 0.0000 | 0.0% | $0.0005 | $0.0005 | $0.0005 | 20,701 | |
| $0.0005 | 0.0000 | 0.0% | $0.0005 | $0.0005 | $0.0005 | 5,100 | |
| $0.0005 | -0.0002 | -28.6% | $0.0005 | $0.0005 | $0.0005 | 759 | |
| $0.0007 | 0.0000 | 0.0% | $0.0007 | $0.0007 | $0.0007 | 0 | |
| $0.0007 | 0.0000 | 0.0% | $0.0007 | $0.0007 | $0.0007 | 0 | |
| $0.0007 | 0.0000 | 0.0% | $0.0005 | $0.0007 | $0.0005 | 569 | |
| $0.0007 | 0.0000 | 0.0% | $0.0007 | $0.0007 | $0.0007 | 0 | |
| $0.0007 | 0.0000 | 0.0% | $0.0007 | $0.0007 | $0.0007 | 0 | |
| $0.0007 | 0.0000 | 0.0% | $0.0005 | $0.0007 | $0.0005 | 20,965 | |
| $0.0007 | 0.0000 | 0.0% | $0.0007 | $0.0007 | $0.0007 | 0 | |
| $0.0007 | 0.0000 | 0.0% | $0.0007 | $0.0007 | $0.0007 | 0 | |
| $0.0007 | 0.0000 | 0.0% | $0.0007 | $0.0007 | $0.0007 | 0 | |
| $0.0007 | 0.0000 | 0.0% | $0.0007 | $0.0007 | $0.0007 | 0 | |
| $0.0007 | 0.0000 | 0.0% | $0.0007 | $0.0007 | $0.0007 | 0 | |
| $0.0007 | 0.0000 | 0.0% | $0.0007 | $0.0007 | $0.0007 | 0 | |
| $0.0007 | 0.0000 | 0.0% | $0.0007 | $0.0007 | $0.0007 | 0 | |
| $0.0007 | 0.0000 | 0.0% | $0.0007 | $0.0007 | $0.0007 | 0 | |
| $0.0007 | 0.0000 | 0.0% | $0.0007 | $0.0007 | $0.0007 | 0 | |
| $0.0007 | +0.0002 | +40.0% | $0.0007 | $0.0007 | $0.0007 | 3,500 | |
| $0.0005 | 0.0000 | 0.0% | $0.0005 | $0.0005 | $0.0005 | 1,577 | |
| $0.0005 | 0.0000 | 0.0% | $0.0005 | $0.0005 | $0.0005 | 0 | |
| $0.0005 | 0.0000 | 0.0% | $0.0005 | $0.0005 | $0.0005 | 0 | |
| $0.0005 | 0.0000 | 0.0% | $0.0005 | $0.0005 | $0.0005 | 0 | |
| $0.0005 | 0.0000 | 0.0% | $0.0005 | $0.0005 | $0.0005 | 0 | |
| $0.0005 | 0.0000 | 0.0% | $0.0005 | $0.0005 | $0.0005 | 0 | |
| $0.0005 | -0.0002 | -28.6% | $0.0005 | $0.0005 | $0.0005 | 257 | |
| $0.0007 | 0.0000 | 0.0% | $0.0007 | $0.0007 | $0.0007 | 0 | |
| $0.0007 | 0.0000 | 0.0% | $0.0007 | $0.0007 | $0.0007 | 0 | |
| $0.0007 | 0.0000 | 0.0% | $0.0007 | $0.0007 | $0.0007 | 0 | |
| $0.0007 | +0.0002 | +40.0% | $0.0007 | $0.0007 | $0.0007 | 180 | |
| $0.0005 | -0.0002 | -28.6% | $0.0005 | $0.0005 | $0.0005 | 117 | |
| $0.0007 | +0.0002 | +40.0% | $0.0007 | $0.0007 | $0.0007 | 451 | |
| $0.0005 | 0.0000 | 0.0% | $0.0005 | $0.0005 | $0.0005 | 0 | |
| $0.0005 | 0.0000 | 0.0% | $0.0005 | $0.0005 | $0.0005 | 0 | |
| $0.0005 | 0.0000 | 0.0% | $0.0005 | $0.0005 | $0.0005 | 147 | |
| $0.0005 | -0.0002 | -28.6% | $0.0005 | $0.0005 | $0.0005 | 400 | |
| $0.0007 | +0.0002 | +40.0% | $0.0007 | $0.0007 | $0.0007 | 112 | |
| $0.0005 | 0.0000 | 0.0% | $0.0005 | $0.0005 | $0.0005 | 299 | |
| $0.0005 | 0.0000 | 0.0% | $0.0005 | $0.0005 | $0.0005 | 0 | |
| $0.0005 | 0.0000 | 0.0% | $0.0005 | $0.0005 | $0.0005 | 0 | |
| $0.0005 | 0.0000 | 0.0% | $0.0005 | $0.0005 | $0.0005 | 0 | |
| $0.0005 | 0.0000 | 0.0% | $0.0005 | $0.0005 | $0.0005 | 0 | |
| $0.0005 | 0.0000 | 0.0% | $0.0005 | $0.0005 | $0.0005 | 1,004 | |
| $0.0005 | 0.0000 | 0.0% | $0.0005 | $0.0005 | $0.0005 | 0 | |
| $0.0005 | 0.0000 | 0.0% | $0.0005 | $0.0005 | $0.0005 | 0 | |
| $0.0005 | 0.0000 | 0.0% | $0.0005 | $0.0005 | $0.0005 | 0 | |
| $0.0005 | 0.0000 | 0.0% | $0.0005 | $0.0005 | $0.0005 | 0 | |
| $0.0005 | 0.0000 | 0.0% | $0.0005 | $0.0005 | $0.0005 | 0 | |
| $0.0005 | 0.0000 | 0.0% | $0.0005 | $0.0005 | $0.0005 | 0 | |
| $0.0005 | 0.0000 | 0.0% | $0.0005 | $0.0005 | $0.0005 | 0 | |
| $0.0005 | -0.0002 | -28.6% | $0.0005 | $0.0005 | $0.0005 | 139 | |
| $0.0007 | +0.0002 | +40.0% | $0.0007 | $0.0007 | $0.0007 | 246 | |
| $0.0005 | -0.0002 | -28.6% | $0.0005 | $0.0005 | $0.0005 | 1,788 | |
| $0.0007 | 0.0000 | 0.0% | $0.0007 | $0.0007 | $0.0007 | 0 | |
| $0.0007 | 0.0000 | 0.0% | $0.0007 | $0.0007 | $0.0007 | 0 | |
| $0.0007 | 0.0000 | 0.0% | $0.0007 | $0.0007 | $0.0007 | 0 | |
| $0.0007 | 0.0000 | 0.0% | $0.0007 | $0.0007 | $0.0007 | 106 | |
| $0.0007 | 0.0000 | 0.0% | $0.0007 | $0.0007 | $0.0007 | 0 | |
| $0.0007 | 0.0000 | 0.0% | $0.0007 | $0.0007 | $0.0007 | 0 | |
| $0.0007 | +0.0002 | +40.0% | $0.0007 | $0.0007 | $0.0007 | 3,000 | |
| $0.0005 | 0.0000 | 0.0% | $0.0005 | $0.0005 | $0.0005 | 0 | |
| $0.0005 | -0.0003 | -37.5% | $0.0005 | $0.0005 | $0.0005 | 35,820 | |
| $0.0008 | 0.0000 | 0.0% | $0.0008 | $0.0008 | $0.0008 | 0 | |
| $0.0008 | +0.0001 | +14.3% | $0.0008 | $0.0008 | $0.0008 | 207 | |
| $0.0007 | 0.0000 | 0.0% | $0.0007 | $0.0007 | $0.0007 | 0 | |
| $0.0007 | +0.0002 | +40.0% | $0.0007 | $0.0007 | $0.0007 | 860 |
Splits
1 split · OTC:PXMD · every price before a split is adjusted for it
| Day | Ratio | What |
|---|---|---|
| 1-for-17 | Consolidation |
- Ticker
- OTC:PXMD
- Asset type
- Stock
- Sector
- Health care
- Industry
- Biotechnology
- Exchange
- OTC
- Currency
- USD
Latest news
Kuvatris Therapeutics, Inc. SEC 10-Q Report
Jan 14, 2026
Closed $0.0001 (0.0%) on Jan 15, 2026
PaxMedica, Inc. on 6ix
- Sector
- Health care
- Industry
- Biotechnology
- News releases
- 1 in the last 12 months · 1 in all · newest Jan 14, 2026 · oldest 2026
- Decks
- 4 decks · latest Mar 13, 2024
Where PaxMedica, Inc. is listed
| Listing | Exchange | Country | Currency |
|---|---|---|---|
| OTC:PXMD · Home listing · This page | OTC | United States | USD |
| BIVA:PXMD | BIVA | Mexico | MXN |
| BMV:PXMD | BMV | Mexico | MXN |
Valuation
price Nov 18, 2026
- Enterprise value
- No statements on 6ix yet
- P/E
- No statements on 6ix yet
- EV/sales
- No statements on 6ix yet
- EV/EBITDA
- No statements on 6ix yet
- Price/book
- No statements on 6ix yet
- Gross margin
- No statements on 6ix yet
- Operating margin
- No statements on 6ix yet
- Net margin
- No statements on 6ix yet
- Debt to equity
- No statements on 6ix yet
- Beta vs S&P 500
- 0.10
Biotechnology: the 10 companies nearest in size, of 890 on 6ix with figures. Size in US dollars.
| Company | Mkt cap | EV | P/E | EV/Sales | EV/EBITDA | P/B | Net mgn | Debt/Eq | Beta |
|---|---|---|---|---|---|---|---|---|---|
| PaxMedica, Inc. · OTC:PXMD | US$63,132 | n/a | n/a | n/a | n/a | n/a | n/a | n/a | 0.10 |
| Vaxil Bio Ltd. · TSXV:VXL | US$319,500 | −US$4,070 | 1.2× | n/a | n/a | 0.4× | n/a | 0.0× | -0.16 |
| Chimeric Therapeutics Limited · ASX:CHM | US$292,816 | −US$220,193 | n/a | −0.1× | n/a | 0.2× | −262.8% | 2.5× | n/a |
| CERo Therapeutics Holdings, Inc. · OTC:CERO | US$265,035 | −US$190,890 | n/a | n/a | n/a | n/a | n/a | n/a | 1.47 |
| CDT Equity Inc. · NASDAQ:CDT | US$234,109 | −US$1.49M | n/a | n/a | n/a | 0.0× | n/a | 0.0× | 1.14 |
| GlucoTrack, Inc. · NASDAQ:GCTK | US$217,049 | −US$887,951 | n/a | n/a | n/a | n/a | n/a | n/a | 1.73 |
| Regen BioPharma, Inc. · OTC:RGBP | US$167,528 | US$167,289 | n/a | 0.7× | n/a | n/a | −501.4% | n/a | 1.20 |
| CNBX Pharmaceuticals Inc. · OTC:CNBX | US$160,577 | US$151,090 | n/a | n/a | n/a | n/a | n/a | n/a | 1.78 |
| Fifty 1 Labs Inc. · OTC:FITY | US$118,532 | US$282,021 | n/a | 6,000× | n/a | n/a | n/a | n/a | -1.17 |
| GB Sciences, Inc. · OTC:GBLX | US$81,414 | US$2.07M | n/a | n/a | n/a | n/a | n/a | n/a | -0.46 |
| Lyra Therapeutics, Inc. · OTC:LYRA | US$53,246 | US$14.42M | n/a | 36.2× | n/a | n/a | n/a | n/a | 0.67 |
| Median of the others | US$192,289 | US$73,510 | 1.2× | 18.5× | 0.2× | −382.1% | 0.0× | 1.14 |
Events
| Quarter | Results |
|---|---|
| Q3 2024 | Nov 29, 2024 |
| Q2 2024 | Sep 20, 2024 |
| Q1 2024 | May 13, 2024 · After close |
| Q4 2023 | Mar 11, 2024 · After close |
| Q3 2023 | Nov 16, 2023 · After close |
| Q2 2023 | Aug 30, 2023 |
| Q4 2022 | Mar 30, 2023 |
| Q3 2022 | Nov 14, 2022 |
| Q2 2022 | Aug 29, 2022 |
| Q4 2021 | Jan 4, 2022 |
Decks
| Deck | Kind | Slides | Date |
|---|---|---|---|
| Investor Presentation (March 2024) | Investor deck | 17 slides | Mar 13, 2024 |
| Investor Presentation (December 2022) | Investor deck | 24 slides | Dec 19, 2022 |
| Investor Presentation (October 2022) | Investor deck | 24 slides | Oct 12, 2022 |
| IPO Roadshow (August 2020) | IPO roadshow | 29 slides | Aug 28, 2020 |
Financials
Annual, in USD
Income statement
| Line | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 |
|---|---|---|---|---|---|---|
| Revenue | 0 | 0 | 0 | 0 | 0 | |
| Research and development | 3.92M | 1.79M | 2.23M | 936.8K | 484.1K | |
| Selling, general and administrative | 12.2B | 8.82M | 4.97M | 4.63M | 114.5K | |
| Operating income | -16.1M | -10.6M | -7.20M | -5.57M | -598.6K | |
| Depreciation and amortization | 2.13M | 5.90M | 173.4K | 53.5K | 171.9K | |
| EBITDA | -14.0M | -4.70M | -7.02M | -5.51M | -426.7K | |
| Interest expense | 9.16K | 5.24K | 2.81M | 609.5K | 0 | 0 |
| Income before tax | -18.3M | -14.8M | -10.2M | -7.83M | -598.6K | |
| Income tax | -167.9K | 4.19M | 2.81M | 663.0K | -171.9K | |
| Net income | -18.3M | -14.8M | -13.0M | -8.49M | -598.6K | |
| Earnings per share, basic | -11.00 | -28.79 | -18.81 | -14.41 | -1.02 |
Balance sheet
| Line | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 |
|---|---|---|---|---|---|---|
| Cash and equivalents | 4.71M | 1.90M | 444.1K | 1.12M | 24.9K | 9.32K |
| Receivables | 0 | 0 | ||||
| Current assets | 5.68M | 2.20M | 444.1K | 1.12M | 24.9K | 9.32K |
| Total assets | 5.68M | 2.20M | 648.9K | 1.12M | 24.9K | 9.32K |
| Accounts payable | 830.2K | 722.0K | 736.3K | 346.1K | 41.0K | 2.45K |
| Current liabilities | 1.80M | 2.10M | 10.8M | 5.75M | 123.2K | 6.60K |
| Total debt | 173.5K | 611.6K | ||||
| Total liabilities | 2.30M | 2.10M | 10.8M | 5.75M | 123.2K | 6.60K |
| Shareholders' equity | 3.39M | 108.8K | -10.1M | -4.63M | -98.3K | 2.72K |
| Shares outstanding | 1.66M | 514.2K | 692.9K | 589.2K | 589.2K | 9.86M |
Cash flow
| Line | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 |
|---|---|---|---|---|---|---|
| Cash from operations | -10.8M | -6.07M | -5.51M | -2.35M | -419.4K | -279.9K |
| Capital spending | 0 | 0 | 0 | 0 | 0 | 0 |
| Free cash flow | -10.8M | -6.07M | -5.51M | -2.35M | -419.4K | -279.9K |
| Cash from investing | -7.70K | |||||
| Cash from financing | 13.6M | 7.53M | 4.83M | 3.45M | 435.0K | 300.0K |
| Dividends paid | -11.9B | -35.0K | ||||
| Share buybacks | -196.0K | -35.0K | ||||
| Change in cash | 2.81M | 1.46M | -679.5K | 1.10M | 15.6K | 12.4K |
Cap table
Built by 6ix from PaxMedica, Inc.’s releases
- Common shares
- 126,264,370
- Fully diluted
- 126,264,370
Fully diluted
| Line | Shares |
|---|---|
| Common shares | 126,264,370 |
Share count over time
| Count | Shares |
|---|---|
| Nov 22, 2026 | 126,264,370 |
People
6ix reads each seat by machine from the page it links to, and can misread one.
| Person | Seat |
|---|---|
| Charles J. Casamento Other companies: GT Biopharma, Inc. (Independent Director · Since at least May 1, 2023); Eton Pharmaceuticals, Inc. (Director · Since at least Nov 9, 2018); Relmada Therapeutics, Inc. (Chairman of the Board · Since at least Oct 20, 2017); GridAI Technologies Corp. (Director · Mar 3, 2017 – Jan 2, 2024 · Past); International Stem Cell Corporation (Director · Mar 31, 2016 – Jun 21, 2018 · Past) | Director · Oct 1, 2022 – Mar 12, 2024 · Past |
| Zachary Rome Other companies: Timber Pharmaceuticals Inc (Director · May 18, 2020 – Mar 4, 2022 · Past) | Director · Aug 12, 2022 – Mar 12, 2024 · Past |
| John F Coelho | Director · Aug 12, 2022 – Mar 12, 2024 · Past |
| Karen LaRochelle | Director · Aug 12, 2022 – Mar 12, 2024 · Past |
Log in to ask 6ix AI your own questions about PaxMedica, Inc.